Ibuprofen arginate is the more soluble arginate salt form of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen. Ibuprofen arginate retains the inhibitory potency against COX-2 as ibuprofen and its sodium salt, however only ibuprofen arginate is able to augment cellular NO pathway through codelivery of the NOS substrate arginine.
The global market for Ibuprofen Arginine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Ibuprofen Arginine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ibuprofen Arginine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Ibuprofen Arginine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Ibuprofen Arginine include Newstar Chem Enterprise, Chemos, BuGuCh and Partners, Aozeal Certified Standards, LEAPChem, Spedifen, Pipelinepharma, Solpharma and Zambon, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ibuprofen Arginine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ibuprofen Arginine by region & country, by Type, and by Application.
The Ibuprofen Arginine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ibuprofen Arginine.
Market Segmentation
By Company
Newstar Chem Enterprise
Chemos
BuGuCh and Partners
Aozeal Certified Standards
LEAPChem
Spedifen
Pipelinepharma
Solpharma
Zambon
Alcami
Boots
Nurofen
Pfizer
China Resources Pharmaceutical Group
Anhui Huachen
Shanghai Taihao
Hangzhou Dayang
Segment by Type:
Granules
Tablets
Segment by Application
Toothache
Dysmenorrhea
Arthralgia
Headache
Fever Caused by Influenza
Traumatic Pain
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ibuprofen Arginine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ibuprofen Arginine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ibuprofen Arginine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Ibuprofen Arginine Product Introduction
1.2 Global Ibuprofen Arginine Market Size Forecast
1.2.1 Global Ibuprofen Arginine Sales Value (2019-2030)
1.2.2 Global Ibuprofen Arginine Sales Volume (2019-2030)
1.2.3 Global Ibuprofen Arginine Sales Price (2019-2030)
1.3 Ibuprofen Arginine Market Trends & Drivers
1.3.1 Ibuprofen Arginine Industry Trends
1.3.2 Ibuprofen Arginine Market Drivers & Opportunity
1.3.3 Ibuprofen Arginine Market Challenges
1.3.4 Ibuprofen Arginine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ibuprofen Arginine Players Revenue Ranking (2023)
2.2 Global Ibuprofen Arginine Revenue by Company (2019-2024)
2.3 Global Ibuprofen Arginine Players Sales Volume Ranking (2023)
2.4 Global Ibuprofen Arginine Sales Volume by Company Players (2019-2024)
2.5 Global Ibuprofen Arginine Average Price by Company (2019-2024)
2.6 Key Manufacturers Ibuprofen Arginine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Ibuprofen Arginine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ibuprofen Arginine
2.9 Ibuprofen Arginine Market Competitive Analysis
2.9.1 Ibuprofen Arginine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Ibuprofen Arginine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ibuprofen Arginine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Granules
3.1.2 Tablets
3.2 Global Ibuprofen Arginine Sales Value by Type
3.2.1 Global Ibuprofen Arginine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ibuprofen Arginine Sales Value, by Type (2019-2030)
3.2.3 Global Ibuprofen Arginine Sales Value, by Type (%) (2019-2030)
3.3 Global Ibuprofen Arginine Sales Volume by Type
3.3.1 Global Ibuprofen Arginine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Ibuprofen Arginine Sales Volume, by Type (2019-2030)
3.3.3 Global Ibuprofen Arginine Sales Volume, by Type (%) (2019-2030)
3.4 Global Ibuprofen Arginine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Toothache
4.1.2 Dysmenorrhea
4.1.3 Arthralgia
4.1.4 Headache
4.1.5 Fever Caused by Influenza
4.1.6 Traumatic Pain
4.1.7 Others
4.2 Global Ibuprofen Arginine Sales Value by Application
4.2.1 Global Ibuprofen Arginine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ibuprofen Arginine Sales Value, by Application (2019-2030)
4.2.3 Global Ibuprofen Arginine Sales Value, by Application (%) (2019-2030)
4.3 Global Ibuprofen Arginine Sales Volume by Application
4.3.1 Global Ibuprofen Arginine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Ibuprofen Arginine Sales Volume, by Application (2019-2030)
4.3.3 Global Ibuprofen Arginine Sales Volume, by Application (%) (2019-2030)
4.4 Global Ibuprofen Arginine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Ibuprofen Arginine Sales Value by Region
5.1.1 Global Ibuprofen Arginine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ibuprofen Arginine Sales Value by Region (2019-2024)
5.1.3 Global Ibuprofen Arginine Sales Value by Region (2025-2030)
5.1.4 Global Ibuprofen Arginine Sales Value by Region (%), (2019-2030)
5.2 Global Ibuprofen Arginine Sales Volume by Region
5.2.1 Global Ibuprofen Arginine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Ibuprofen Arginine Sales Volume by Region (2019-2024)
5.2.3 Global Ibuprofen Arginine Sales Volume by Region (2025-2030)
5.2.4 Global Ibuprofen Arginine Sales Volume by Region (%), (2019-2030)
5.3 Global Ibuprofen Arginine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Ibuprofen Arginine Sales Value, 2019-2030
5.4.2 North America Ibuprofen Arginine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Ibuprofen Arginine Sales Value, 2019-2030
5.5.2 Europe Ibuprofen Arginine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Ibuprofen Arginine Sales Value, 2019-2030
5.6.2 Asia Pacific Ibuprofen Arginine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Ibuprofen Arginine Sales Value, 2019-2030
5.7.2 South America Ibuprofen Arginine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ibuprofen Arginine Sales Value, 2019-2030
5.8.2 Middle East & Africa Ibuprofen Arginine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ibuprofen Arginine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ibuprofen Arginine Sales Value
6.2.1 Key Countries/Regions Ibuprofen Arginine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Ibuprofen Arginine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Ibuprofen Arginine Sales Value, 2019-2030
6.3.2 United States Ibuprofen Arginine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ibuprofen Arginine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ibuprofen Arginine Sales Value, 2019-2030
6.4.2 Europe Ibuprofen Arginine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ibuprofen Arginine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ibuprofen Arginine Sales Value, 2019-2030
6.5.2 China Ibuprofen Arginine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ibuprofen Arginine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ibuprofen Arginine Sales Value, 2019-2030
6.6.2 Japan Ibuprofen Arginine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ibuprofen Arginine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ibuprofen Arginine Sales Value, 2019-2030
6.7.2 South Korea Ibuprofen Arginine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ibuprofen Arginine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ibuprofen Arginine Sales Value, 2019-2030
6.8.2 Southeast Asia Ibuprofen Arginine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ibuprofen Arginine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ibuprofen Arginine Sales Value, 2019-2030
6.9.2 India Ibuprofen Arginine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ibuprofen Arginine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Newstar Chem Enterprise
7.1.1 Newstar Chem Enterprise Company Information
7.1.2 Newstar Chem Enterprise Introduction and Business Overview
7.1.3 Newstar Chem Enterprise Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Newstar Chem Enterprise Ibuprofen Arginine Product Offerings
7.1.5 Newstar Chem Enterprise Recent Development
7.2 Chemos
7.2.1 Chemos Company Information
7.2.2 Chemos Introduction and Business Overview
7.2.3 Chemos Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Chemos Ibuprofen Arginine Product Offerings
7.2.5 Chemos Recent Development
7.3 BuGuCh and Partners
7.3.1 BuGuCh and Partners Company Information
7.3.2 BuGuCh and Partners Introduction and Business Overview
7.3.3 BuGuCh and Partners Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BuGuCh and Partners Ibuprofen Arginine Product Offerings
7.3.5 BuGuCh and Partners Recent Development
7.4 Aozeal Certified Standards
7.4.1 Aozeal Certified Standards Company Information
7.4.2 Aozeal Certified Standards Introduction and Business Overview
7.4.3 Aozeal Certified Standards Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Aozeal Certified Standards Ibuprofen Arginine Product Offerings
7.4.5 Aozeal Certified Standards Recent Development
7.5 LEAPChem
7.5.1 LEAPChem Company Information
7.5.2 LEAPChem Introduction and Business Overview
7.5.3 LEAPChem Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 LEAPChem Ibuprofen Arginine Product Offerings
7.5.5 LEAPChem Recent Development
7.6 Spedifen
7.6.1 Spedifen Company Information
7.6.2 Spedifen Introduction and Business Overview
7.6.3 Spedifen Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Spedifen Ibuprofen Arginine Product Offerings
7.6.5 Spedifen Recent Development
7.7 Pipelinepharma
7.7.1 Pipelinepharma Company Information
7.7.2 Pipelinepharma Introduction and Business Overview
7.7.3 Pipelinepharma Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pipelinepharma Ibuprofen Arginine Product Offerings
7.7.5 Pipelinepharma Recent Development
7.8 Solpharma
7.8.1 Solpharma Company Information
7.8.2 Solpharma Introduction and Business Overview
7.8.3 Solpharma Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Solpharma Ibuprofen Arginine Product Offerings
7.8.5 Solpharma Recent Development
7.9 Zambon
7.9.1 Zambon Company Information
7.9.2 Zambon Introduction and Business Overview
7.9.3 Zambon Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Zambon Ibuprofen Arginine Product Offerings
7.9.5 Zambon Recent Development
7.10 Alcami
7.10.1 Alcami Company Information
7.10.2 Alcami Introduction and Business Overview
7.10.3 Alcami Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Alcami Ibuprofen Arginine Product Offerings
7.10.5 Alcami Recent Development
7.11 Boots
7.11.1 Boots Company Information
7.11.2 Boots Introduction and Business Overview
7.11.3 Boots Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Boots Ibuprofen Arginine Product Offerings
7.11.5 Boots Recent Development
7.12 Nurofen
7.12.1 Nurofen Company Information
7.12.2 Nurofen Introduction and Business Overview
7.12.3 Nurofen Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Nurofen Ibuprofen Arginine Product Offerings
7.12.5 Nurofen Recent Development
7.13 Pfizer
7.13.1 Pfizer Company Information
7.13.2 Pfizer Introduction and Business Overview
7.13.3 Pfizer Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Pfizer Ibuprofen Arginine Product Offerings
7.13.5 Pfizer Recent Development
7.14 China Resources Pharmaceutical Group
7.14.1 China Resources Pharmaceutical Group Company Information
7.14.2 China Resources Pharmaceutical Group Introduction and Business Overview
7.14.3 China Resources Pharmaceutical Group Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 China Resources Pharmaceutical Group Ibuprofen Arginine Product Offerings
7.14.5 China Resources Pharmaceutical Group Recent Development
7.15 Anhui Huachen
7.15.1 Anhui Huachen Company Information
7.15.2 Anhui Huachen Introduction and Business Overview
7.15.3 Anhui Huachen Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Anhui Huachen Ibuprofen Arginine Product Offerings
7.15.5 Anhui Huachen Recent Development
7.16 Shanghai Taihao
7.16.1 Shanghai Taihao Company Information
7.16.2 Shanghai Taihao Introduction and Business Overview
7.16.3 Shanghai Taihao Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Shanghai Taihao Ibuprofen Arginine Product Offerings
7.16.5 Shanghai Taihao Recent Development
7.17 Hangzhou Dayang
7.17.1 Hangzhou Dayang Company Information
7.17.2 Hangzhou Dayang Introduction and Business Overview
7.17.3 Hangzhou Dayang Ibuprofen Arginine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Hangzhou Dayang Ibuprofen Arginine Product Offerings
7.17.5 Hangzhou Dayang Recent Development
8 Industry Chain Analysis
8.1 Ibuprofen Arginine Industrial Chain
8.2 Ibuprofen Arginine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ibuprofen Arginine Sales Model
8.5.2 Sales Channel
8.5.3 Ibuprofen Arginine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Newstar Chem Enterprise
Chemos
BuGuCh and Partners
Aozeal Certified Standards
LEAPChem
Spedifen
Pipelinepharma
Solpharma
Zambon
Alcami
Boots
Nurofen
Pfizer
China Resources Pharmaceutical Group
Anhui Huachen
Shanghai Taihao
Hangzhou Dayang
听
听
*If Applicable.